Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Indocyanine green during cholecystectomy in acute cholecystitis
2024-518677-34-00Phase 4Authorised
- Sponsor
- Fundació Parc Taulí
- Start
- Nov 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of indocyanine green in acute cholecystitis (2 arms), sponsored by Fundació Parc Taulí. Primary endpoint: Surgical time. Planned start Nov 2024; status: authorised.
02
Drugs
indocyanine green
03
Conditions
acute cholecystitis
Beyond the preview
Go deeper on 2024-518677-34-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2024-518677-34-00.